Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ALHC · against 446 other Healthcare companies of similar size
Ranked #183 of 447 · scores higher than 58% of peers
Bars: peers in each 10-point band of the valuation score43 peers with a valuation score of 60–69, including ALHC · Click a bar to see the companies
Mainly thanks to its free cash flow yield and EBITDA yield, which are stronger than most Healthcare peers.
| Metric | ALHC | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 435 reported | 2.6% | 1.4% | 58% | 30% | |
| EBITDA yieldHigher is better · 448 reported | 7.5% | 4.3% | 68% | 50% | |
| Free cash flow yieldHigher is better · 205 reported | 11.6% | -0.5% | 93% | 20% | |
| Book yieldHigher is better · 437 reported | 17.3% | 38.6% | 21% | Context only |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score